Guillain-Barré syndrome and its treatment.
Autor(es): Douglas Michael R.; Winer John B.
Resumo: Guillain-Barré syndrome typically presents with an acute ascending areflexic weakness, progressing over 4 weeks or less. The most common form of the disease is an acute inflammatory demyelinating polyneuropathy, but other forms with primarily axonal pathologies are well documented. The association of Guillain-Barré syndrome with a range of antecedent infections, particularly Campylobacter jejuni enteritis, is also established. A range of serological and neurophysiological investigations can assist in making an accurate diagnosis. Background information about the syndrome and the evidence base for such treatments are discussed herein.
Imprenta: Expert Review of Neurotherapeutics, v. 6, n. 10, p. 1569-1574, 2006
Identificador do objeto digital: 10.1586/14737175.6.10.1569
Descritores: Guillain-Barre Syndrome - Pathogenesis ; Guillain-Barre Syndrome - Serological diagnosis
Data de publicação: 2006
